INCY - Incyte Corp.
IEX Last Trade
65.66
-0.250 -0.381%
Share volume: 2,548,261
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$65.91
-0.25
-0.38%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-07 | 2023-05-02 | 2023-08-01 | 2023-10-31 | 2024-02-13 | 2024-04-30 | 2024-07-30 | |
| Total revenue | 823.303 M | 926.700 M | 808.673 M | 954.610 M | 919.025 M | 1.013 B | 880.889 M | 1.044 B | |
| Cost of revenue | 54.584 M | 59.163 M | 56.822 M | 68.326 M | 60.091 M | 69.751 M | 60.956 M | 76.634 M | |
| Gross profit | 768.719 M | 867.537 M | 751.851 M | 886.284 M | 858.934 M | 943.590 M | 819.933 M | 967.125 M | |
| 12.85% | -13.33% | 17.88% | -3.09% | 9.86% | -13.10% | 17.95% | |||
| Operating expenses | 650.467 M | 774.179 M | 722.247 M | 684.679 M | 643.602 M | 738.359 M | 729.516 M | 1.444 B | |
| Selling general and admin | 266.460 M | 272.819 M | 315.606 M | 283.929 M | 267.893 M | 293.865 M | 300.256 M | 305.982 M | |
| Research and development | 384.007 M | 501.360 M | 406.641 M | 400.750 M | 375.709 M | 444.494 M | 429.260 M | 1.138 B | |
| Total expenses | 705.051 M | 833.342 M | 779.069 M | 753.005 M | 703.693 M | 808.110 M | 790.472 M | 1.521 B | |
| 18.20% | -6.51% | -3.35% | -6.55% | 14.84% | -2.18% | 92.42% | |||
| Operating income | 118.252 M | 93.358 M | 29.604 M | 201.605 M | 215.332 M | 205.231 M | 90.417 M | -477.237 M | |
| Ebit | 118.252 M | 93.358 M | 29.604 M | 201.605 M | 215.332 M | 205.231 M | 90.417 M | -477.237 M | |
| Pretax income | 148.588 M | 80.615 M | 51.856 M | 277.604 M | 233.799 M | 270.956 M | 236.159 M | -389.777 M | |
| -45.75% | -35.67% | 435.34% | -15.78% | 15.89% | -12.84% | -265.05% | |||
| Income tax | 35.813 M | 52.154 M | 30.153 M | 74.056 M | 62.530 M | 69.877 M | 66.611 M | 54.824 M | |
| Net income basic | 112.775 M | 28.461 M | 21.703 M | 203.548 M | 171.269 M | 201.079 M | 169.548 M | -444.601 M | |
| -74.76% | -23.74% | 837.88% | -15.86% | 17.41% | -15.68% | -362.23% | |||
| Net income | 112.775 M | 28.461 M | 21.703 M | 203.548 M | 171.269 M | 201.079 M | 169.548 M | -444.601 M | |
| -74.76% | -23.74% | 837.88% | -15.86% | 17.41% | -15.68% | -362.23% |